Performance Improvement 2013-2014. What Has Been the Impact of the New York City Opioid Analgesic Prescribing Guidelines on Prescribing and Use Behaviors and Does Academic Detailing Increase Impact of the Guidelines?


In collaboration with the Centers for Disease Control and Prevention, the New York City Department of Health and Mental Hygiene conducted an evaluation of the latter's opioid prescribing guidelines. The guidelines were designed to help clinicians determine when opioid analgesics are appropriate for acute pain or chronic non-cancer pain and provide clinicians with clear, instructive guidance for prescribing practices of opioid analgesics to increase the safety and appropriateness of prescriptions. The guidelines also intend to reduce incidence of abuse and overdose with opioid analgesics while improving patient care.

Public Health Detailing appears to be an acceptable and effective public health strategy to change knowledge and attitudes among healthcare providers related to opioid prescribing. When issuing opioid prescribing guidelines, an active approach (e.g., public health detailing campaign) versus a passive approach (e.g., mailing or posting guidelines) is ideal to disseminate and promote use of guidelines.

 Report Title: Evaluation of New York City's Opioid Analgesic Prescribing Guidelines
Agency Sponsor: CDC, Centers for Disease Control and Prevention
Federal Contact: Thomas Chapel, 404-639-2116
Performer: NYC DOHMH in association with PHS and NNPHI
Record ID: 10012 (September 30, 2013)

View full report


"PerformanceImprovement2014.pdf" (pdf, 671.65Kb)

Note: Documents in PDF format require the Adobe Acrobat Reader®. If you experience problems with PDF documents, please download the latest version of the Reader®